Fexofenadine Hydrochloride
NDC Package 43353-760-53
Package Information
Fexofenadine Hydrochloride is adults and children 12 years of age and overtake one 60 mg tablet with water every 12 hours; do not take more than 2 tablets in 24 hourschildren under 12 years of agedo not useadults 65 years of age and olderask a doctorconsumers with kidney diseaseask a doctor. Marketed by Aphena Pharma Solutions - Tennessee, Llc, this product is identified by NDC 43353-760 and is authorized under FDA application ANDA077081.
Identification & Billing
- RxCUI: 997420 - fexofenadine HCl 180 MG 24 HR Oral Tablet
- RxCUI: 997420 - fexofenadine hydrochloride 180 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 43353 - Aphena Pharma Solutions - Tennessee, Llc
- 43353-760 - Fexofenadine Hydrochloride
- 43353-760-53 - 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
- 43353-760 - Fexofenadine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (43353-760). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43353-760-53 identifies a specific commercial package of 30 tablet, film coated in 1 bottle, plastic of Fexofenadine Hydrochloride, labeled by Aphena Pharma Solutions - Tennessee, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Aphena Pharma Solutions - Tennessee, Llc on March 20, 2014. The current certification is valid through December 31, 2018.
How is this Aphena Pharma Solutions - Tennessee, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43353076053. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.